Stay updated on Carfilzomib, Iberdomide, Dexamethasone Clinical Trial

Sign up to get notified when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Difference
    0.0%
    Check dated 2024-06-06T14:47:35.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying that researchers are looking for newly diagnosed multiple myeloma patients, with at least 25% being high risk as defined by IMWG or mSMART criteria. Additionally, it outlines specific inclusion and exclusion criteria for patient enrollment.
    Difference
    17%
    Check dated 2024-05-22T21:36:13.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-04-30T21:47:34.000Z thumbnail image

Stay in the know with updates to Carfilzomib, Iberdomide, Dexamethasone Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.